Proton radiation as boost therapy for localized prostatic carcinoma

Area of Science:

• Radiation Oncology
• Medical Physics
• Urologic Oncology

Background:

• Localized tumors require precise radiation delivery to maximize efficacy and minimize toxicity to surrounding normal tissues.
• Proton beam therapy offers physical advantages over conventional photon (x-ray) therapy due to its finite range and reduced dose deposition beyond the target.
• Prostate cancer treatment often involves complex radiation techniques to adequately cover the prostate while avoiding critical structures like the rectum.

Purpose of the Study:

• To evaluate the efficacy and toxicity of a perineal proton beam technique as boost therapy for localized prostate carcinoma.
• To assess the feasibility of delivering escalated radiation doses to the prostate tumor using a precision proton beam.
• To determine the impact of this technique on rectal and urethral toxicity.

Main Methods:

• Seventeen patients with localized prostatic carcinoma were treated with a 160-MeV proton beam.
• A perineal proton technique was employed for boost therapy, delivering 2,000 to 2,500 rads.
• Treatment involved precise daily irradiation of the target volume with accuracy of +/- 2 mm.

Main Results:

• The total radiation dose to the prostatic tumor was escalated by 500 to 700 rads compared to conventional schedules.
• No significant rectal reactions were observed in patients after 12 to 27 months of follow-up.
• Two patients developed easily managed urethral strictures; local tumor control was achieved in all but one patient.

Conclusions:

• The perineal proton beam technique allows for precise, escalated radiation delivery to localized prostate tumors.
• This method demonstrates a favorable toxicity profile, with minimal rectal complications observed.
• Proton therapy shows promise for improving local control rates in prostate cancer with acceptable side effects.